Literature DB >> 15191401

Cytochromes P450 are differently expressed in normal and varicose human saphenous veins: linkage with varicosis.

Céline Bertrand-Thiebault1, Luc Ferrari, Odile Boutherin-Falson, Mark Kockx, Stéphanie Desquand-Billiald, Jean-Marc Fichelle, Rémi Nottin, Jean-François Renaud, Anne-Marie Batt, Sophie Visvikis.   

Abstract

The expression of cytochrome P450 (CYP) enzymes and cyclo-oxygenases (COX) was investigated in human saphenous veins by reverse transcription-polymerase chain reaction analysis. Non-varicose veins were obtained from patients undergoing aortocoronary bypass grafting, whereas varicose veins were obtained from patients undergoing stripping removal of varicose saphenous veins. In non-varicose veins, CYP1B1, CYP2C, CYP2E1 and CYP4A11 were detected, whereas CYP2J2, CYP3A5, COX-1 and COX-2 were detected almost exclusively in varicose veins. CYP4F2 was not detectable. Except for CYP4A11, the levels of individual CYP mRNA were higher in varicose veins than in control veins. Smooth muscle cell volume, determined by a colour image-analysis system, was increased approximately 1.5-fold in varicose veins. Because CYPs and COXs produce various vasoactive compounds, increased expression of these enzymes could be involved in the impairment of vascular tone and may contribute to varicose pathology. Then, CYP or COX modulators may be potentially active in the treatment of chronic venous insufficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191401     DOI: 10.1111/j.1440-1681.2004.03996.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  4 in total

1.  Improvements of venous tone with pycnogenol in chronic venous insufficiency: an ex vivo study on venous segments.

Authors:  Gianni Belcaro; Mark Dugall; Roberta Luzzi; M Hosoi; Marcello Corsi
Journal:  Int J Angiol       Date:  2014-03

2.  Absence of inflammatory conditions in human varicose saphenous veins.

Authors:  Ingrid Gomez; Chabha Benyahia; Julien Le Dall; Christine Payré; Liliane Louedec; Guy Leséche; Gérard Lambeau; Dan Longrois; Xavier Norel
Journal:  Inflamm Res       Date:  2012-12-13       Impact factor: 4.575

Review 3.  Roles of the epoxygenase CYP2J2 in the endothelium.

Authors:  Ara Askari; Scott J Thomson; Matthew L Edin; Darryl C Zeldin; David Bishop-Bailey
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-03-06       Impact factor: 3.072

4.  CYP1B1 as a therapeutic target in cardio-oncology.

Authors:  Alexa N Carrera; Marianne K O Grant; Beshay N Zordoky
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.